Aramark
F:0AK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Aramark
F:0AK
|
US |
|
S
|
SSE PLC
XMUN:SCT
|
UK |
|
Adf Group Inc
TSX:DRX
|
CA |
|
Abeona Therapeutics Inc
F:PCJ
|
US |
|
Bluelinx Holdings Inc
F:FZG1
|
US |
|
T
|
Tidewater Midstream and Infrastructure Ltd
OTC:TWMIF
|
CA |
|
O
|
OceanaGold Corp
XMUN:RQQ
|
CA |
|
Duke Royalty Ltd
F:B34
|
GG |
|
T
|
Telo Genomics Corp
F:3D0A
|
CA |
Wall St Price Targets
0AK Price Targets Summary
Aramark
According to Wall Street analysts, the average 1-year price target for 0AK is 33.79 EUR with a low forecast of 23.52 EUR and a high forecast of 38.14 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0AK's stock price target?
Price Target
33.79
EUR
According to Wall Street analysts, the average 1-year price target for 0AK is 33.79 EUR with a low forecast of 23.52 EUR and a high forecast of 38.14 EUR.
What is the Revenue forecast for Aramark?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 6 years is 7%.
What is the Operating Income forecast for Aramark?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 6 years is 14%.
What is the Net Income forecast for Aramark?
Projected CAGR
21%
Over the last 13 years, the compound annual growth rate for Net Income has been 9%. The projected CAGR for the next 6 years is 21%.
